An uncommon genetic condition known as familial hypocalciuric hypercalcemia (FHH) is characterized by chronically high calcium levels in the blood (hypercalcemia), but low calcium excretion in the urine (hypocalciuric). It usually runs in families and is brought on by mutations in the genes that control calcium homeostasis. Although FHH often causes no symptoms or major health problems, it can occasionally be mistaken for other illnesses such as primary hyperparathyroidism.
Hi, Welcome to icliniq.com. I understand your concern. Yes, Denosumab can increase parathyroid levels, especially if there is kidney impairment.
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.
